How would you approach therapy for BR-refractory Waldenstrom Macroglobulinemia when there is a mixed response to zanabrutinib?
1 Answer
Mednet Member
Hematology · University of California Irvine
Answered on
It goes without saying this is a “data-free zone.” I would consider extrapolating from CLL and adding venetoclax.
Join for free or sign in to see the full answer